CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alnylam Pharmaceuticals, Inc. Company Snapshot
Alnylam Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alnylam Pharmaceuticals with three other companies in this sector in the United States: Heron Therapeutics Inc (2018 sales of $77.47 million of which 100% was Polymer Technologies), Palatin Technologies, Inc. ($67.13 million of which 100% was Licenses, Grants and Contracts), and Aquestive Therapeutics Inc ($67.43 million ).

Sales Analysis. During the year ended December of 2018, sales at Alnylam Pharmaceuticals were $74.91 million. This is a decrease of 16.7% versus 2017, when the company's sales were $89.91 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alnylam Pharmaceuticals, Inc.
  Stock Performance Chart for Alnylam Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 93.03
(Figures in U.S. Dollars)
1 Week 2.2%   13 Weeks 17.8%  
4 Weeks 15.2%   52 Weeks 28.5%  
 
Alnylam Pharmaceuticals, Inc. Key Data:
  Ticker: ALNY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 74,908,000
(Year Ending Jan 2019).
Employees: 1,065
  Currency: U.S. Dollars Market Cap: 10,356,564,750
  Fiscal Yr Ends: December Shares Outstanding: 111,325,000
  Share Type: Common Closely Held Shares: 926,594
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.